— Know what they know.
Not Investment Advice
Also trades as: CGN.DE (XETRA) · $vol 0M

CI NYSE

Cigna Corporation
1W: -4.4% 1M: +2.7% 3M: +1.2% YTD: +1.0% 1Y: -11.9% 3Y: +16.1% 5Y: +16.5%
$286.24
+4.22 (+1.50%)
 
Weekly Expected Move ±4.1%
$262 $273 $285 $297 $309
NYSE · Healthcare · Medical - Healthcare Plans · Alpha Radar Neutral · Power 54 · $75.7B mcap · 263M float · 0.641% daily turnover · Short 42% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.0 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 11.8%  ·  5Y Avg: 8.3%
Cost Advantage
31
Intangibles
14
Switching Cost
27
Network Effect
50
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CI has No discernible competitive edge (36.0/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 11.8% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$302
Low
$344
Avg Target
$400
High
Based on 8 analysts since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 29Hold: 9Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$342.33
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 UBS $375 $400 +25 +41.8% $282.02
2026-05-20 Morgan Stanley $355 $361 +6 +23.9% $291.28
2026-05-20 Deutsche Bank $304 $302 -2 +3.7% $291.28
2026-05-05 Bernstein $307 $371 +64 +32.8% $279.35
2026-05-01 Raymond James Sarah James $360 $340 -20 +19.3% $285.11
2026-05-01 Robert W. Baird $372 $337 -35 +18.0% $285.60
2026-05-01 Mizuho Securities $325 $330 +5 +15.6% $285.54
2026-05-01 Barclays $303 $310 +7 +6.7% $290.58
2026-04-20 Jefferies $310 $330 +20 +18.4% $278.64
2026-02-17 Truist Financial $338 $350 +12 +19.5% $292.76
2026-02-10 Deutsche Bank $415 $304 -111 +4.4% $291.17
2026-02-09 Truist Financial $320 $338 +18 +14.9% $294.20
2026-02-09 UBS $294 $375 +81 +28.1% $292.84
2026-02-06 Barclays Andrew Mok $305 $303 -2 +6.5% $284.53
2026-01-09 Mizuho Securities $291 $325 +34 +14.5% $283.91
2026-01-06 Bernstein $294 $307 +13 +6.9% $287.10
2026-01-05 Truist Financial $375 $320 -55 +14.6% $279.12
2026-01-05 Barclays $300 $305 +5 +9.3% $279.12
2025-12-15 Cowen & Co. Charles Rhyee $235 $333 +98 +21.1% $274.87
2025-12-02 Guggenheim $388 $318 -70 +16.2% $273.57
2025-11-12 Bernstein Initiated $294 +8.3% $271.57
2025-11-12 UBS $244 $294 +50 +9.7% $268.00
2025-11-05 Wells Fargo $354 $300 -54 +13.4% $264.66
2025-11-04 Goldman Sachs Scott Fidel $370 $330 -40 +27.6% $258.62
2025-11-03 Jefferies David Windley $407 $310 -97 +26.8% $244.41
2025-10-31 Morgan Stanley Erin Wright $390 $355 -35 +46.1% $243.00
2025-10-31 Barclays $382 $300 -82 +22.4% $245.10
2025-10-14 Goldman Sachs Scott Fidel $233 $370 +137 +25.2% $295.41
2025-10-07 Wells Fargo $341 $354 +13 +16.8% $302.99
2025-09-02 Truist Financial David MacDonald $330 $375 +45 +24.7% $300.72
2025-08-14 Robert W. Baird Michael Ha $388 $372 -16 +30.1% $286.00
2025-08-05 Deutsche Bank George Hill $370 $415 +45 +53.3% $270.74
2025-05-06 Guggenheim Jason Cassorla Initiated $388 +16.2% $333.82
2025-05-05 Morgan Stanley Erin Wright $379 $390 +11 +17.1% $333.01
2025-05-05 Barclays Andrew Mok $275 $382 +107 +14.7% $333.01
2025-02-04 Wells Fargo Stephen Baxter $278 $341 +63 +17.0% $291.46
2025-02-03 Piper Sandler Jessica Tassan $400 $348 -52 +19.0% $292.46
2025-01-31 Raymond James John Ransom $400 $360 -40 +22.4% $294.21
2025-01-31 Morgan Stanley Erin Wright $365 $379 +14 +28.8% $294.21
2025-01-31 RBC Capital Ben Hendrix $384 $355 -29 +20.7% $294.21
2024-06-25 Piper Sandler Jessica Tassan Initiated $400 +18.1% $338.80
2024-05-29 Robert W. Baird Michael Ha Initiated $388 +16.5% $332.92
2024-05-06 Jefferies David Windley $271 $407 +136 +19.2% $341.50
2024-05-03 Oppenheimer Michael Wiederhorn $285 $400 +115 +16.1% $344.50
2024-05-03 Raymond James Sarah James $372 $400 +28 +16.1% $344.50
2024-05-03 RBC Capital Ben Hendrix Initiated $384 +11.5% $344.50
2024-02-05 Raymond James Sarah James $350 $372 +22 +14.8% $324.06
2024-02-01 Deutsche Bank George Hill $284 $370 +86 +20.4% $307.32
2023-02-07 Leerink Partners Initiated $335 +15.9% $289.00
2023-02-06 Raymond James $370 $350 -20 +21.3% $288.44

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
5
ROE
4
ROA
4
D/E
1
P/E
3
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CI receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-05-06 A A-
2026-04-30 C+ A
2026-04-30 A- C+
2026-04-01 B+ A-
2026-03-30 A- B+
2026-02-26 C+ A-
2026-02-05 B+ C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

60 Grade B
Profitability
23
Balance Sheet
48
Earnings Quality
86
Growth
64
Value
75
Momentum
90
Safety
65
Cash Flow
61
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CI scores highest in Momentum (90/100) and lowest in Profitability (23/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.68
Grey Zone
Piotroski F-Score
8/9
Beneish M-Score
-2.34
Unlikely Manipulator
Ohlson O-Score
-7.51
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 59.9/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.40x
Accruals: -1.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CI scores 2.68, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CI scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CI's score of -2.34 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CI's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CI receives an estimated rating of BBB (score: 59.9/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CI's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
11.95x
PEG
0.39x
P/S
0.27x
P/B
1.78x
P/FCF
9.20x
P/OCF
8.00x
EV/EBITDA
7.90x
EV/Revenue
0.34x
EV/EBIT
10.11x
EV/FCF
12.31x
Earnings Yield
8.92%
FCF Yield
10.87%
Shareholder Yield
5.29%
Graham Number
$290.75
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 12.0x earnings, CI trades at a reasonable valuation. An earnings yield of 8.9% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $290.75 per share, suggesting a potential 2% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.765
NI / EBT
×
Interest Burden
0.881
EBT / EBIT
×
EBIT Margin
0.034
EBIT / Rev
×
Asset Turnover
1.771
Rev / Assets
×
Equity Multiplier
3.792
Assets / Equity
=
ROE
15.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CI's ROE of 15.2% is driven by financial leverage (equity multiplier: 3.79x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
1.65%
Fair P/E
11.81x
Intrinsic Value
$281.02
Price/Value
0.95x
Margin of Safety
5.08%
Premium
-5.08%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CI's realized 1.7% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $281.02, CI appears undervalued with a 5% margin of safety. The adjusted fair P/E of 11.8x compares to the current market P/E of 12.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$286.26
Median 1Y
$297.64
5th Pctile
$173.38
95th Pctile
$513.55
Ann. Volatility
33.2%
Analyst Target
$342.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David M. Cordani
Chair and Chief Executive Officer
$1,600,000 $13,929,161 $22,866,134
Brian C. Evanko
President and Chief Operating Officer
$1,073,077 $5,056,613 $9,998,401
Nicole S. Jones
Executive Vice President, Chief Administrative Officer, and General Counsel
$893,173 $2,949,613 $5,955,936
Ann M. Dennison
Executive Vice President, Chief Financial Officer, The Cigna Group
$773,077 $2,307,330 $4,691,526
Everett Neville President,
Vice President, Strategy and Business Development
$800,000 $1,685,847 $4,073,915

CEO Pay Ratio

111:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $22,866,134
Avg Employee Cost (SGA/emp): $206,795
Employees: 67,700

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
67,700
-7.9% YoY
Revenue / Employee
$4,061,329
Rev: $274,952,000,000
Profit / Employee
$87,991
NI: $5,957,000,000
SGA / Employee
$206,795
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 17.0% 17.5% 11.0% 11.1% 11.3% 13.6% 14.6% 14.7% 14.5% 11.6% 11.3% 7.9% 8.1% 6.7% 7.9% 11.5% 11.5% 14.1% 14.4% 15.2% 15.20%
ROA 5.2% 5.4% 3.5% 3.5% 3.5% 4.3% 4.5% 4.5% 4.5% 3.6% 3.5% 2.4% 2.5% 2.0% 2.2% 3.3% 3.3% 4.0% 3.8% 4.0% 4.01%
ROIC 8.1% 8.3% 8.4% 8.6% 8.9% 8.8% 9.8% 9.7% 9.6% 9.7% 12.2% 12.4% 12.7% 13.2% 10.4% 11.1% 11.1% 11.6% 11.5% 11.8% 11.85%
ROCE 6.4% 6.6% 7.3% 7.6% 7.8% 7.7% 8.3% 8.1% 7.9% 8.2% 8.7% 9.0% 9.2% 9.4% 9.9% 10.0% 9.9% 9.9% 9.2% 9.2% 9.18%
Gross Margin 13.1% 13.3% 12.5% 13.5% 13.5% 12.7% 12.4% 12.9% 12.6% 13.2% 12.9% 11.2% 10.8% 10.4% 9.8% 10.1% 11.7% 8.5% 7.7% 9.4% 9.45%
Operating Margin 5.0% 5.2% 3.4% 5.0% 5.2% 4.7% 3.8% 4.3% 4.6% 4.6% 4.0% 3.9% 4.0% 4.0% 3.3% 3.0% 3.6% 3.7% 3.0% 3.4% 3.44%
Net Margin 3.4% 3.7% 2.4% 2.7% 3.4% 6.1% 2.6% 2.7% 3.0% 2.9% 2.0% -0.5% 2.6% 1.2% 2.2% 2.0% 2.3% 2.7% 1.7% 2.4% 2.41%
EBITDA Margin 6.7% 6.8% 5.5% 6.7% 6.9% 6.3% 5.4% 5.9% 6.1% 6.5% 6.1% 5.3% 5.3% 5.2% 4.5% 4.7% 4.5% 4.8% 3.5% 4.4% 4.39%
FCF Margin 2.9% 3.6% 3.5% 3.9% 4.7% 5.3% 4.1% 5.6% 6.1% 5.7% 5.2% 4.9% 3.7% 2.2% 3.6% 2.4% 1.5% 2.8% 3.1% 2.8% 2.76%
OCF Margin 3.6% 4.2% 4.1% 4.6% 5.4% 6.0% 4.8% 6.4% 6.9% 6.6% 6.0% 5.6% 4.3% 2.8% 4.2% 2.9% 2.0% 3.2% 3.5% 3.2% 3.17%
ROE 3Y Avg snapshot only 11.72%
ROE 5Y Avg snapshot only 12.35%
ROA 3Y Avg snapshot only 3.19%
ROIC 3Y Avg snapshot only 7.41%
ROIC Economic snapshot only 11.48%
Cash ROA snapshot only 5.58%
Cash ROIC snapshot only 13.45%
CROIC snapshot only 11.69%
NOPAT Margin snapshot only 2.79%
Pretax Margin snapshot only 2.96%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 5.01%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 9.25 7.47 13.14 13.34 14.21 12.15 14.29 10.72 11.92 15.31 16.47 27.82 24.61 31.30 21.89 18.23 17.48 12.50 12.29 11.21 11.951
P/S Ratio 0.45 0.37 0.40 0.41 0.43 0.45 0.53 0.40 0.43 0.43 0.44 0.49 0.42 0.41 0.30 0.36 0.33 0.29 0.27 0.25 0.272
P/B Ratio 1.50 1.24 1.50 1.53 1.66 1.71 2.13 1.62 1.77 1.82 1.84 2.18 1.97 2.06 1.83 2.24 2.14 1.87 1.75 1.69 1.780
P/FCF 15.34 10.36 11.68 10.40 9.29 8.40 13.01 7.09 6.97 7.49 8.30 9.91 11.47 18.35 8.39 15.27 22.24 10.34 8.73 9.20 9.201
P/OCF 12.60 8.68 9.80 8.86 8.07 7.43 11.07 6.23 6.17 6.55 7.20 8.66 9.71 14.37 7.25 12.33 16.57 8.87 7.62 8.00 7.998
EV/EBITDA 9.23 7.86 8.91 8.82 9.13 9.46 10.52 8.64 9.40 9.30 8.88 9.95 9.01 9.26 7.93 9.24 9.04 8.13 8.09 7.90 7.901
EV/Revenue 0.58 0.50 0.57 0.57 0.59 0.60 0.67 0.53 0.56 0.56 0.55 0.60 0.52 0.50 0.40 0.45 0.43 0.38 0.35 0.34 0.339
EV/EBIT 12.66 10.74 12.11 11.88 12.24 12.72 14.16 11.74 12.84 12.62 11.87 13.18 11.85 12.00 10.20 11.80 11.51 10.39 10.37 10.11 10.112
EV/FCF 19.83 14.01 16.36 14.48 12.65 11.36 16.37 9.51 9.14 9.76 10.47 12.10 14.25 22.63 11.04 19.22 28.26 13.53 11.56 12.31 12.306
Earnings Yield 10.8% 13.4% 7.6% 7.5% 7.0% 8.2% 7.0% 9.3% 8.4% 6.5% 6.1% 3.6% 4.1% 3.2% 4.6% 5.5% 5.7% 8.0% 8.1% 8.9% 8.92%
FCF Yield 6.5% 9.6% 8.6% 9.6% 10.8% 11.9% 7.7% 14.1% 14.3% 13.4% 12.0% 10.1% 8.7% 5.4% 11.9% 6.6% 4.5% 9.7% 11.5% 10.9% 10.87%
PEG Ratio snapshot only 0.391
EV/OCF snapshot only 10.698
EV/Gross Profit snapshot only 3.647
Acquirers Multiple snapshot only 9.906
Shareholder Yield snapshot only 5.29%
Graham Number snapshot only $290.75
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.77 0.77 0.83 0.83 0.83 0.83 0.73 0.73 0.73 0.73 0.77 0.77 0.77 0.77 0.84 0.84 0.84 0.84 0.85 0.85 0.849
Quick Ratio 0.68 0.68 0.74 0.74 0.74 0.74 0.61 0.61 0.61 0.61 0.65 0.65 0.65 0.65 0.73 0.73 0.73 0.73 0.72 0.72 0.718
Debt/Equity 0.67 0.67 0.73 0.73 0.73 0.73 0.70 0.70 0.70 0.70 0.67 0.67 0.67 0.67 0.78 0.78 0.78 0.78 0.75 0.75 0.754
Net Debt/Equity 0.44 0.44 0.60 0.60 0.60 0.60 0.55 0.55 0.55 0.55 0.48 0.48 0.48 0.48 0.58 0.58 0.58 0.58 0.57 0.57 0.570
Debt/Assets 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.20 0.20 0.20 0.20 0.21 0.21 0.21 0.21 0.20 0.20 0.199
Debt/EBITDA 3.18 3.11 3.09 3.01 2.94 2.98 2.76 2.80 2.85 2.76 2.56 2.50 2.46 2.44 2.56 2.56 2.59 2.58 2.63 2.64 2.637
Net Debt/EBITDA 2.09 2.05 2.55 2.49 2.43 2.46 2.16 2.20 2.23 2.16 1.84 1.80 1.76 1.75 1.90 1.90 1.93 1.92 1.99 1.99 1.994
Interest Coverage 5.99 6.30 6.75 7.08 7.26 7.14 6.93 6.44 6.02 5.97 6.25 6.61 6.73 6.82 6.76 6.64 6.74 6.88 6.77 6.77 6.775
Equity Multiplier 3.09 3.09 3.29 3.29 3.29 3.29 3.21 3.21 3.21 3.21 3.30 3.30 3.30 3.30 3.80 3.80 3.80 3.80 3.79 3.79 3.786
Cash Ratio snapshot only 0.136
Debt Service Coverage snapshot only 8.671
Cash to Debt snapshot only 0.244
FCF to Debt snapshot only 0.243
Defensive Interval snapshot only 814.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 1.07 1.09 1.12 1.14 1.16 1.16 1.21 1.23 1.25 1.27 1.32 1.39 1.47 1.57 1.60 1.65 1.70 1.74 1.75 1.77 1.771
Inventory Turnover 49.33 50.47 43.88 44.71 45.25 45.58 36.95 37.52 38.26 38.97 32.64 34.63 36.84 39.63 35.85 37.15 38.02 39.11 35.49 35.94 35.936
Receivables Turnover 14.90 15.20 13.08 13.31 13.49 13.56 11.43 11.59 11.79 12.02 11.35 11.97 12.66 13.51 11.91 12.30 12.63 12.92 10.41 10.52 10.522
Payables Turnover 8.36 8.56 7.41 7.55 7.64 7.70 6.71 6.81 6.95 7.08 6.39 6.78 7.22 7.76 6.69 6.93 7.09 7.30 10.28 10.41 10.413
DSO 24 24 28 27 27 27 32 31 31 30 32 30 29 27 31 30 29 28 35 35 34.7 days
DIO 7 7 8 8 8 8 10 10 10 9 11 11 10 9 10 10 10 9 10 10 10.2 days
DPO 44 43 49 48 48 47 54 54 53 52 57 54 51 47 55 53 51 50 35 35 35.1 days
Cash Conversion Cycle -12 -11 -13 -13 -13 -13 -13 -12 -12 -12 -14 -13 -12 -11 -14 -13 -13 -12 10 10 9.8 days
Fixed Asset Turnover snapshot only 76.128
Operating Cycle snapshot only 44.8 days
Cash Velocity snapshot only 36.209
Capital Intensity snapshot only 0.568
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 7.9% 8.4% 8.5% 8.7% 7.6% 6.1% 3.7% 3.3% 3.7% 5.2% 8.2% 12.6% 17.1% 22.5% 26.6% 24.0% 20.3% 15.3% 11.3% 8.8% 8.84%
Net Income 54.9% 58.2% -36.6% -36.0% -32.6% -21.0% 25.0% 25.4% 21.6% -19.6% -23.0% -46.6% -44.5% -43.0% -33.5% 39.1% 35.3% 1.0% 73.5% 24.9% 24.91%
EPS 65.0% 72.1% -30.5% -29.9% -26.3% -13.2% 34.9% 34.8% 29.1% -16.8% -20.1% -44.2% -42.0% -39.8% -29.5% 40.7% 43.4% 1.1% 81.2% 33.9% 33.89%
FCF -47.4% -22.2% -34.8% -18.4% 70.9% 58.5% 21.9% 47.8% 35.8% 13.7% 39.1% -0.8% -30.3% -52.4% -12.5% -40.8% -50.5% 43.5% -6.3% 27.5% 27.45%
EBITDA -7.2% -2.8% -2.5% 2.2% 10.2% 6.7% 3.4% -0.9% -4.7% -0.6% 5.4% 9.7% 13.5% 10.9% 3.4% 1.2% -2.0% -2.3% -4.0% -4.6% -4.55%
Op. Income -9.9% -7.5% -2.7% 1.5% 11.0% 6.4% 6.5% 1.4% -3.1% -0.2% 1.0% 6.0% 10.3% 13.1% 10.3% 4.0% 2.1% -1.6% -3.1% 4.2% 4.20%
OCF Growth snapshot only 18.39%
Asset Growth snapshot only 1.31%
Equity Growth snapshot only 1.66%
Debt Growth snapshot only -1.59%
Shares Change snapshot only -6.71%
Dividend Growth snapshot only 2.41%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 56.2% 56.0% 53.0% 33.1% 20.5% 11.7% 5.5% 5.9% 6.4% 6.6% 6.8% 8.1% 9.3% 11.0% 12.4% 13.0% 13.5% 14.1% 15.1% 14.9% 14.94%
Revenue 5Y 33.9% 34.1% 34.4% 34.5% 34.5% 34.3% 34.0% 33.8% 33.6% 33.5% 32.0% 22.3% 16.3% 12.4% 10.0% 10.6% 11.1% 11.3% 11.4% 11.3% 11.28%
EPS 3Y 31.5% 29.7% 14.4% 27.8% 21.3% 23.7% 16.8% 20.0% 16.2% 7.5% -9.2% -19.2% -17.9% -24.2% -8.8% 1.9% 2.4% 2.1% 0.7% 1.7% 1.65%
EPS 5Y 25.1% 27.5% 17.4% 17.5% 14.9% 18.3% 19.6% 16.9% 16.7% 9.5% 10.0% 9.4% 6.0% -1.1% -2.1% 6.3% 5.5% 9.7% -0.9% -0.1% -0.15%
Net Income 3Y 47.4% 44.8% 26.7% 20.5% 14.1% 15.8% 9.5% 11.3% 8.3% 0.2% -15.2% -24.6% -23.1% -28.7% -13.8% -2.3% -3.0% -2.5% -3.9% -2.5% -2.45%
Net Income 5Y 32.4% 34.4% 23.5% 22.6% 19.5% 23.0% 24.5% 21.5% 21.3% 14.1% 14.4% 3.2% 0.1% -6.6% -7.6% 0.5% -0.9% 3.0% -6.8% -5.7% -5.71%
EBITDA 3Y 27.2% 25.1% 24.5% 15.0% 7.6% 1.0% -0.4% 0.1% -0.9% 1.0% 2.0% 3.5% 6.0% 5.6% 4.0% 3.2% 2.0% 2.5% 1.5% 1.9% 1.94%
EBITDA 5Y 21.9% 22.5% 22.1% 22.3% 21.5% 21.1% 20.5% 17.7% 16.6% 15.7% 16.0% 10.6% 6.2% 2.6% 1.5% 2.2% 1.6% 2.2% 1.1% 1.4% 1.40%
Gross Profit 3Y 15.4% 14.4% 12.0% 7.7% 4.4% 0.7% -2.1% -1.6% -2.0% -0.5% 1.3% 2.1% 4.0% 4.2% 4.2% 4.2% 5.2% 4.6% 3.4% 3.1% 3.10%
Gross Profit 5Y 13.1% 12.9% 12.6% 12.0% 11.8% 10.9% 10.8% 10.1% 9.4% 9.5% 9.0% 6.6% 4.5% 2.5% 0.7% 1.1% 1.9% 1.8% 1.4% 1.5% 1.51%
Op. Income 3Y -9.2% 0.9% 24.0% 17.1% 11.3% 5.2% 1.5% 1.5% -1.0% -0.6% 1.5% 2.9% 5.9% 6.3% 5.9% 3.8% 2.9% 3.6% 2.6% 4.8% 4.76%
Op. Income 5Y -9.4% -9.1% -8.9% -8.9% -9.0% -10.0% -10.6% -7.9% -4.3% 1.7% 15.5% 11.5% 8.1% 5.6% 3.1% 2.9% 1.8% 1.8% 2.3% 3.4% 3.41%
FCF 3Y 4.3% 17.3% 23.0% 17.1% 26.2% 17.6% -4.4% 13.2% 6.9% 11.9% 3.4% 6.2% 17.4% -5.0% 14.1% -4.6% -22.3% -8.1% 4.5% -9.2% -9.22%
FCF 5Y 16.5% 11.2% 11.1% 10.2% 12.3% 18.9% 15.3% 20.4% 21.4% 23.8% 25.9% 18.7% 13.8% -2.5% 1.2% -3.2% -15.8% -0.9% -1.9% -2.0% -2.03%
OCF 3Y 7.4% 19.6% 24.0% 18.1% 24.7% 16.7% -3.0% 12.5% 7.4% 12.0% 4.5% 6.8% 16.2% -2.8% 13.0% -2.9% -18.2% -7.2% 3.5% -8.9% -8.90%
OCF 5Y 15.8% 11.5% 11.7% 11.2% 13.5% 19.4% 16.2% 20.8% 21.7% 24.2% 25.7% 18.7% 13.5% -0.6% 1.8% -1.9% -12.7% -0.4% -1.5% -1.6% -1.61%
Assets 3Y 36.0% 36.0% 0.4% 0.4% 0.4% 0.4% -2.6% -2.6% -2.6% -2.6% -0.6% -0.6% -0.6% -0.6% 0.2% 0.2% 0.2% 0.2% 3.2% 3.2% 3.15%
Assets 5Y 22.2% 22.2% 21.1% 21.1% 21.1% 21.1% 18.4% 18.4% 18.4% 18.4% -0.1% -0.1% -0.1% -0.1% 0.0% 0.0% 0.0% 0.0% 0.3% 0.3% 0.32%
Equity 3Y 54.2% 54.2% 4.7% 4.7% 4.7% 4.7% -0.3% -0.3% -0.3% -0.3% -2.8% -2.8% -2.8% -2.8% -4.5% -4.5% -4.5% -4.5% -2.4% -2.4% -2.40%
Book Value 3Y 37.5% 38.1% -5.5% 11.1% 11.3% 11.9% 6.3% 7.4% 7.0% 6.9% 4.0% 4.1% 3.7% 3.3% 1.1% -0.4% 0.8% -0.0% 2.2% 1.7% 1.70%
Dividend 3Y 2.2% 2.7% 3.0% 65.0% 33.5% 18.1% 7.8% 8.9% 8.5% 8.6% 8.7% 9.3% 9.4% 9.0% 8.6% 6.5% 7.2% 6.0% 5.7% 5.0% 5.04%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.87 0.86 0.82 0.91 0.95 0.92 0.82 0.83 0.84 0.84 0.84 0.90 0.95 0.94 0.82 0.85 0.88 0.90 0.89 0.92 0.915
Earnings Stability 0.85 0.89 0.67 0.67 0.70 0.82 0.58 0.58 0.59 0.40 0.16 0.02 0.00 0.05 0.28 0.16 0.22 0.16 0.40 0.24 0.237
Margin Stability 0.60 0.57 0.55 0.59 0.57 0.54 0.52 0.50 0.49 0.48 0.49 0.67 0.77 0.82 0.84 0.84 0.84 0.83 0.82 0.82 0.819
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.85 0.86 0.87 0.92 0.90 0.90 0.91 0.92 0.91 0.81 0.82 0.83 0.87 0.84 0.86 0.50 0.50 0.90 0.900
Earnings Smoothness 0.57 0.55 0.55 0.56 0.61 0.77 0.78 0.77 0.81 0.78 0.74 0.39 0.43 0.45 0.60 0.67 0.70 0.32 0.46 0.78 0.778
ROE Trend 0.06 0.06 -0.03 -0.02 -0.02 -0.00 0.01 0.01 0.01 -0.03 -0.02 -0.05 -0.05 -0.06 -0.05 0.01 0.01 0.06 0.05 0.05 0.050
Gross Margin Trend -0.04 -0.03 -0.03 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.00 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.020
FCF Margin Trend -0.02 -0.01 -0.02 -0.01 0.00 0.01 -0.01 0.01 0.02 0.01 0.01 0.00 -0.02 -0.03 -0.01 -0.03 -0.03 -0.01 -0.01 -0.01 -0.009
Sustainable Growth Rate 15.6% 15.4% 8.3% 8.3% 8.5% 10.8% 11.6% 11.7% 11.5% 8.5% 8.2% 4.7% 4.8% 3.3% 4.3% 7.9% 7.9% 10.4% 10.5% 11.3% 11.29%
Internal Growth Rate 5.0% 5.0% 2.7% 2.7% 2.7% 3.5% 3.7% 3.7% 3.7% 2.7% 2.6% 1.5% 1.5% 1.0% 1.2% 2.3% 2.3% 3.0% 2.8% 3.1% 3.07%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.73 0.86 1.34 1.50 1.76 1.63 1.29 1.72 1.93 2.34 2.29 3.21 2.53 2.18 3.02 1.48 1.05 1.41 1.61 1.40 1.401
FCF/OCF 0.82 0.84 0.84 0.85 0.87 0.88 0.85 0.88 0.88 0.88 0.87 0.87 0.85 0.78 0.86 0.81 0.75 0.86 0.87 0.87 0.869
FCF/Net Income snapshot only 1.218
OCF/EBITDA snapshot only 0.739
CapEx/Revenue 0.6% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.8% 0.8% 0.8% 0.8% 0.7% 0.7% 0.6% 0.6% 0.6% 0.5% 0.5% 0.4% 0.4% 0.41%
CapEx/Depreciation snapshot only 0.442
Accruals Ratio 0.01 0.01 -0.01 -0.02 -0.03 -0.03 -0.01 -0.03 -0.04 -0.05 -0.04 -0.05 -0.04 -0.02 -0.04 -0.02 -0.00 -0.02 -0.02 -0.02 -0.016
Sloan Accruals snapshot only -0.013
Cash Flow Adequacy snapshot only 3.184
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.9% 1.6% 1.9% 1.9% 1.7% 1.7% 1.4% 1.9% 1.8% 1.7% 1.7% 1.5% 1.7% 1.6% 2.1% 1.7% 1.8% 2.1% 2.2% 2.3% 2.13%
Dividend/Share $1.99 $3.01 $4.07 $4.21 $4.33 $4.47 $4.53 $4.67 $4.73 $4.80 $4.92 $5.18 $5.33 $5.48 $5.64 $5.57 $5.92 $5.96 $6.06 $6.12 $6.09
Payout Ratio 8.4% 12.1% 25.0% 25.1% 24.8% 20.7% 20.6% 20.6% 21.0% 26.8% 28.1% 41.0% 40.8% 50.7% 45.6% 31.3% 31.6% 26.0% 27.0% 25.7% 25.70%
FCF Payout Ratio 14.0% 16.8% 22.2% 19.5% 16.2% 14.3% 18.8% 13.6% 12.3% 13.1% 14.2% 14.6% 19.0% 29.7% 17.5% 26.3% 40.2% 21.5% 19.2% 21.1% 21.10%
Total Payout Ratio 87.3% 1.1% 1.7% 1.4% 1.4% 1.3% 1.3% 1.3% 1.2% 91.9% 72.3% 1.9% 2.1% 2.3% 2.5% 1.2% 1.2% 1.0% 87.8% 59.3% 59.30%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 44.81 66.82 88.42 2.78 1.00 0.37 0.05 0.05 0.05 0.06 0.06 0.08 0.09 0.10 0.10 0.08 0.07 0.06 0.05 0.05 0.047
Buyback Yield 8.5% 12.8% 11.0% 8.8% 8.2% 9.1% 7.9% 9.9% 8.0% 4.3% 2.7% 5.3% 6.8% 5.8% 9.4% 4.9% 5.3% 6.0% 4.9% 3.0% 3.00%
Net Buyback Yield 7.9% 12.1% 10.5% 8.5% 7.9% 8.6% 7.5% 9.5% 7.7% 4.0% 2.5% 5.0% 6.4% 5.5% 9.0% 4.7% 5.0% 5.8% 4.7% 2.7% 2.73%
Total Shareholder Return 8.9% 13.7% 12.4% 10.3% 9.6% 10.3% 9.0% 11.4% 9.5% 5.8% 4.2% 6.4% 8.0% 7.1% 11.0% 6.4% 6.8% 7.9% 6.9% 5.0% 5.02%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.77 0.77 0.79 0.79 0.79 0.79 0.80 0.80 0.80 0.80 0.94 0.91 0.91 0.88 0.65 0.74 0.73 0.77 0.78 0.77 0.765
Interest Burden (EBT/EBIT) 1.38 1.38 0.83 0.81 0.80 0.98 0.99 1.02 1.03 0.79 0.61 0.43 0.43 0.35 0.54 0.70 0.71 0.82 0.81 0.88 0.881
EBIT Margin 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.034
Asset Turnover 1.07 1.09 1.12 1.14 1.16 1.16 1.21 1.23 1.25 1.27 1.32 1.39 1.47 1.57 1.60 1.65 1.70 1.74 1.75 1.77 1.771
Equity Multiplier 3.25 3.25 3.19 3.19 3.19 3.19 3.25 3.25 3.25 3.25 3.26 3.26 3.26 3.26 3.54 3.54 3.54 3.54 3.79 3.79 3.792
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $23.63 $24.84 $16.28 $16.81 $17.42 $21.55 $21.95 $22.66 $22.49 $17.93 $17.53 $12.64 $13.05 $10.80 $12.36 $17.77 $18.71 $22.92 $22.40 $23.80 $23.80
Book Value/Share $145.89 $149.06 $142.92 $146.64 $149.50 $153.20 $146.92 $150.07 $151.15 $151.02 $156.92 $161.36 $162.73 $164.26 $147.72 $144.88 $153.02 $153.02 $156.85 $157.87 $161.66
Tangible Book/Share $-94.28 $-96.33 $-108.03 $-110.84 $-113.00 $-115.80 $-118.79 $-121.33 $-122.20 $-122.10 $-107.67 $-110.72 $-111.66 $-112.71 $-128.09 $-125.63 $-132.68 $-132.68 $-119.46 $-120.25 $-120.25
Revenue/Share $483.49 $503.89 $528.08 $551.27 $569.49 $586.81 $591.06 $612.14 $626.98 $639.13 $662.89 $719.12 $767.25 $826.54 $889.62 $901.67 $977.33 $999.91 $1033.86 $1051.95 $1058.67
FCF/Share $14.25 $17.90 $18.31 $21.56 $26.66 $31.15 $24.10 $34.24 $38.45 $36.66 $34.76 $35.47 $28.02 $18.42 $32.24 $21.22 $14.71 $27.73 $31.54 $28.99 $29.18
OCF/Share $17.35 $21.36 $21.81 $25.30 $30.68 $35.22 $28.34 $38.98 $43.46 $41.88 $40.10 $40.58 $33.09 $23.52 $37.31 $26.28 $19.73 $32.31 $36.10 $33.35 $33.56
Cash/Share $33.38 $34.10 $18.20 $18.68 $19.04 $19.51 $22.36 $22.84 $23.00 $22.98 $29.69 $30.53 $30.79 $31.08 $29.57 $29.01 $30.64 $30.64 $28.86 $29.05 $29.91
EBITDA/Share $30.61 $31.92 $33.61 $35.39 $36.93 $37.37 $37.49 $37.67 $37.36 $38.45 $40.97 $43.12 $44.31 $45.03 $44.91 $44.14 $46.00 $46.16 $45.05 $45.16 $45.16
Debt/Share $97.30 $99.42 $103.95 $106.65 $108.74 $111.42 $103.31 $105.53 $106.28 $106.19 $105.00 $107.97 $108.89 $109.92 $115.10 $112.89 $119.23 $119.23 $118.30 $119.08 $119.08
Net Debt/Share $63.92 $65.32 $85.74 $87.97 $89.69 $91.91 $80.95 $82.69 $83.28 $83.21 $75.31 $77.44 $78.09 $78.83 $85.52 $83.88 $88.59 $88.59 $89.44 $90.03 $90.03
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.679
Altman Z-Prime snapshot only 1.668
Piotroski F-Score 6 6 6 6 7 6 6 6 6 6 8 7 7 7 7 8 9 8 8 8 8
Beneish M-Score -2.10 -2.24 -2.28 -2.37 -2.46 -2.41 -2.41 -2.49 -2.51 -2.61 -2.66 -2.56 -2.48 -2.33 -2.20 -2.19 -2.22 -2.13 -2.24 -2.34 -2.336
Ohlson O-Score snapshot only -7.508
Net-Net WC snapshot only $-258.24
EVA snapshot only $1211071211.20
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB
Credit Score 50.31 49.72 52.57 56.06 57.56 57.84 54.15 65.61 64.19 64.85 63.78 66.91 53.65 59.39 61.57 57.08 58.50 61.12 63.55 59.95 59.946
Credit Grade snapshot only 9
Credit Trend snapshot only 2.871
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 53
Sector Credit Rank snapshot only 52

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms